A double-blind, randomized, placebo-controlled, interventional, multicenter, phase III clinical trial to investigate the safety and efficacy of ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs) on epidermolysis bullosa (EB)

Is this Study for You?

Let's Get Started!

Details
Age

Child to Adult

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Anna Bruckner

Anna Bruckner

Study ID

Protocol Number: 22-1732

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers